Attached files

file filename
8-K - FORM 8-K - LAM RESEARCH CORPd526506d8k.htm

Exhibit 99.1

FOR IMMEDIATE RELEASE

Lam Research Corporation Contact:

Shanye Hudson, Investor Relations, phone: 510-572-4589, e-mail: shanye.hudson@lamresearch.com

Ed Rebello, Corporate Communications, phone: 510-572-6603, e-mail: edward.rebello@lamresearch.com

Lam Research Corporation Reports Financial Results for the Quarter Ended March 31, 2013

FREMONT, Calif., April 24, 2013—Lam Research Corp. (NASDAQ: LRCX) today announced financial results for the quarter ended March 31, 2013. Highlights for the quarter were as follows:

 

   

Delivered shipments of $896 million during the March 2013 quarter, up 12% from the prior quarter

 

   

Reported revenue of $844.9 million for the March 2013 quarter, down 2% from the prior quarter

 

   

Reported GAAP gross margin of 40.2%, GAAP operating margin of 1.3% and GAAP diluted EPS of $0.11

 

   

Delivered non-GAAP gross margin of 43.9%, non-GAAP operating margin of 8.8%, and non-GAAP EPS of $0.44

 

   

Completed $1.6 billion stock buyback reducing share count by approximately 5 million shares this quarter

Lam Research Corporation

Financial Highlights for the Quarter Ended March 31, 2013

(in thousands, except per share data and percentages)

 

U.S. GAAP

 
     March
2013
    December
2012
    Change Q/Q  

Revenue

   $ 844,928      $ 860,886        -2

Operating Margin

     1.3     0.5     +80 bps   

Net Income

   $ 18,996      $ 6,408        +196.4

Diluted EPS

   $ 0.11      $ 0.04      +$ 0.07   

 

Non-GAAP

 
     March
2013
    December
2012
    Change Q/Q  

Revenue

   $ 844,928      $ 860,886        -2

Operating Margin

     8.8     11.5     -270 bps   

Net Income

   $ 74,474      $ 77,278        -3.6

Diluted EPS

   $ 0.44      $ 0.45      -$ 0.01   

GAAP Financial Results

Revenue for the period was $844.9 million, gross margin was $339.8 million, or 40.2% of revenue, operating expenses were $329.0 million, and net income was $19.0 million, or $0.11 per diluted share on a GAAP basis. This compares to revenue of $860.9 million, gross margin of $315.4 million, or 36.6% of revenue, operating expenses of $311.4 million, and net income of $6.4 million, or $0.04 per diluted share, for the December 2012 quarter.

Non-GAAP Financial Results

Non-GAAP gross margin was $370.7 million, or 43.9% of revenue, non-GAAP operating expenses were $296.0 million, and non-GAAP net income was $74.5 million, or $0.44 per diluted share. This compares to non-GAAP gross margin of $380.5 million, or 44.2% of revenue, non-GAAP operating expenses of $281.5 million, and non-GAAP net income of $77.3 million, or $0.45 per diluted share, for the December 2012 quarter.

“Lam delivered solid March quarter results, which underscore our ability to execute well as a newly integrated company,” stated Martin Anstice, Lam’s president and chief executive officer. “We are off to a great start this year and continue to make progress against our multi-year growth strategic plan by building upon our technology leadership in key product areas and further strengthening our competitive differentiation.”

 

~more~

page 1 of 8


Balance Sheet and Cash Flow Results

Cash and cash equivalents, short-term investments and restricted cash and investment balances decreased to $2.5 billion at the end of the March 2013 quarter, as planned, compared to $2.7 billion at the end of the December 2012 quarter. This decrease was primarily the result of approximately $243 million of stock repurchases, offset by approximately $102 million in cash flow from operating activities during the March 2013 quarter.

Deferred revenue and deferred profit balances at the end of the March 2013 quarter increased to $326.6 million and $193.3 million, respectively, as compared to $282.0 million and $169.0 million, respectively, at the end of the December 2012 quarter. Lam’s deferred revenue balance does not include shipments to Japanese customers, to whom title does not transfer until customer acceptance. Shipments to Japanese customers are classified as inventory at cost until the time of acceptance. The anticipated future revenue from shipments to Japanese customers was approximately $49.9 million as of March 31, 2013.

Geographic Distribution

The geographic distribution of shipments and revenue during the March 2013 quarter is shown in the following table:

 

Region

   Shipments     Revenue  

North America

     21     26

Europe

     9     10

Japan

     11     11

Korea

     12     14

Taiwan

     33     26

Asia Pacific

     14     13

Use of Non-GAAP Financial Results

In addition to U.S. GAAP results, this commentary also contains non-GAAP financial results. The Company’s non-GAAP results for both the March 2013 and December 2012 quarters exclude costs associated with the fair value impact of acquisition-related inventory, amortization related to intangible assets acquired in the Novellus transaction, certain integration-related costs, the amortization of convertible note discounts, and rationalization of certain product configurations. Additionally, the March 2013 quarter non-GAAP results exclude the impairment of an investment, tax benefit on reinstatement of R&D tax credit, and tax expense associated with legal entity integration, and the December 2012 quarter non-GAAP results exclude restructuring charges and tax benefits from the successful resolution of certain tax matters.

Management uses non-GAAP gross margin, operating income, operating expenses, operating margin, net income, and net income per diluted share to evaluate the Company’s operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing the investors’ ability to view the Company’s results from management’s perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company’s web site at http://investor.lamresearch.com.

 

~more~

page 2 of 8


Lam Announces Financial Results for the March 2013 Quarter

Caution Regarding Forward-Looking Statements

Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to, the anticipated revenue from shipments to Japanese customers, our expectations for growth and future demand for semiconductor equipment, our ability to execute as an integrated company, our ability to build on our technology leadership, our ability to strengthen our competitive differentiation, our ability to make progress against multi-year goals, and our plans pertaining to expense management, funding technology investments and positioning our products with customers as well as our ability to execute those plans. Some factors that may affect these forward-looking statements include: business conditions in the consumer electronics industry, the semiconductor industry and the overall economy; the strength of the financial performance of our existing and prospective customers; the introduction of new and innovative technologies; the occurrence and pace of technology transitions and conversions; the actions of our competitors, consumers, semiconductor companies and key suppliers and subcontractors; and the success of research and development and sales and marketing programs. These forward-looking statements are based on current expectations and are subject to uncertainties and changes in condition, significance, value and effect as well as other risks detailed in documents filed by us with the Securities and Exchange Commission, including specifically our report on Form 10-K for the year ended June 24, 2012 and Form 10-Qs for the three months ended September 23, 2012 and December 23, 2012. These uncertainties and changes could cause actual results to vary from expectations. The Company undertakes no obligation to update the information or statements made in this press release.

About Lam Research

Lam Research Corp. is a major supplier of innovative wafer fabrication equipment and services to the worldwide semiconductor industry. For more than 30 years, the Company has driven continuous improvements in chip performance, power consumption, and cost, contributing to the global proliferation of smartphones, computers, tablets, and other electronic products. Lam Research has been the leading supplier of high-throughput plasma etch equipment for more than a decade and expanded its product offerings in 2008 to include single-wafer clean systems. The Company added thin-film deposition and wafer surface preparation technologies to its product portfolio in 2012 with the acquisition of Novellus Systems, Inc. Headquartered in Fremont, Calif., Lam Research maintains a global network of service facilities throughout North America, Asia, and Europe to rapidly meet the needs of its global customer base. It is an S&P 500 ® company whose common stock trades on the NASDAQ Global Select Market SM under the symbol LRCX. For more information, please visit http://www.lamresearch.com.

Consolidated Financial Tables Follow.

 

###

page 3 of 8


Lam Announces Financial Results for the March 2013 Quarter

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data and percentages)

(unaudited)

 

     Three Months Ended     Nine Months Ended  
     March 31,
2013
    December 23,
2012
    March 25,
2012
    March 31,
2013
    March 25,
2012
 

Revenue

   $ 844,928      $ 860,886      $ 658,961      $ 2,612,702      $ 1,923,378   

Cost of goods sold

     505,096        545,472        391,814        1,623,570        1,138,381   

Cost of goods sold - restructuring and impairments

     —          —          —            (859
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total cost of goods sold

     505,096        545,472        391,814        1,623,570        1,137,522   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross margin

     339,832        315,414        267,147        989,132        785,856   

Gross margin as a percent of revenue

     40.2     36.6     40.5     37.9     40.9

Research and development

     174,206        165,951        113,448        503,468        320,031   

Selling, general and administrative

     154,807        144,400        95,581        453,070        259,037   

Restructuring and impairments

     —          1,021        —          1,021        1,725   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     329,013        311,372        209,029        957,559        580,793   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     10,819        4,042        58,118        31,573        205,063   

Operating margin as a percent of revenue

     1.3     0.5     8.8     1.2     10.7

Other expense, net

     (15,834     (13,390     (3,568     (39,162     (23,426
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) before income taxes

     (5,015     (9,348     54,550        (7,589     181,637   

Income tax expense (benefit)

     (24,011     (15,756     8,946        (35,761     30,983   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 18,996      $ 6,408      $ 45,604      $ 28,172      $ 150,654   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income per share:

          

Basic net income per share

   $ 0.12      $ 0.04      $ 0.38      $ 0.16      $ 1.25   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Diluted net income per share

   $ 0.11      $ 0.04      $ 0.38      $ 0.16      $ 1.24   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Number of shares used in per share calculations:

          

Basic

     163,034        170,699        119,841        171,016        120,904   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Diluted

     168,504        173,027        120,956        174,306        121,830   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

page 4 of 8


Lam Announces Financial Results for the March 2013 Quarter

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

 

     March 31,
2013
     December 23,
2012
     June 24,
2012
 
     (unaudited)      (unaudited)      (1)  

ASSETS

        

Cash and cash equivalents

   $ 1,019,109       $ 1,190,189       $ 1,564,752   

Short-term investments

     1,337,819         1,330,498         1,297,931   

Accounts receivable, net

     544,070         590,925         765,818   

Inventories

     545,036         530,272         632,853   

Deferred income taxes

     137,729         139,300         47,782   

Other current assets

     86,156         65,224         105,973   
  

 

 

    

 

 

    

 

 

 

Total current assets

     3,669,919         3,846,408         4,415,109   

Property and equipment, net

     594,916         590,547         584,596   

Restricted cash and investments

     166,196         166,166         166,335   

Goodwill and intangible assets

     2,562,986         2,608,221         2,686,730   

Other assets

     152,285         151,822         151,882   
  

 

 

    

 

 

    

 

 

 

Total assets

   $ 7,146,302       $ 7,363,164       $ 8,004,652   
  

 

 

    

 

 

    

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

        

Current liabilities

   $ 801,013       $ 825,482       $ 1,426,928   
  

 

 

    

 

 

    

 

 

 

Long-term debt, convertible notes, and capital leases

   $ 1,294,599       $ 1,286,729       $ 761,783   

Income taxes payable

     250,339         260,063         274,240   

Other long-term liabilities

     258,151         294,300         219,577   
  

 

 

    

 

 

    

 

 

 

Total liabilities

     2,604,102         2,666,574         2,682,528   
  

 

 

    

 

 

    

 

 

 

Senior convertible notes

     —           —           190,343   

Stockholders’ equity (2)

     4,542,200         4,696,590         5,131,781   
  

 

 

    

 

 

    

 

 

 

Total liabilities and stockholders’ equity

   $ 7,146,302       $ 7,363,164       $ 8,004,652   
  

 

 

    

 

 

    

 

 

 

 

(1) Derived from audited financial statements
(2) Common shares issued and outstanding were 161,802 shares as of March 31, 2013, 165,846 shares as of December 23, 2012, and 186,656 shares as of June 24, 2012.

 

page 5 of 8


Lam Announces Financial Results for the March 2013 Quarter

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

 

     Three Months Ended     Nine Months Ended  
     March 31,
2013
    December 23,
2012
    March 25,
2012
    March 31,
2013
    March 25,
2012
 

CASH FLOWS FROM OPERATING ACTIVITIES:

          

Net income

   $ 18,996      $ 6,408      $ 45,604      $ 28,172      $ 150,654   

Adjustments to reconcile net income to net cash provided by operating activities:

          

Depreciation and amortization

     74,861        78,388        22,517        228,065        66,249   

Deferred income taxes

     (27,934     (7,320     3,723        (47,271     3,090   

Restructuring and impairment charges, net

     —          1,021        —          1,021        866   

Equity-based compensation expense

     25,648        24,027        16,417        74,089        52,385   

Income tax benefit on equity-based compensation plans

     (847     —          (1,048     (847     81   

Excess tax benefit on equity-based compensation plans

     903        —          (137     903        (2,292

Amortization of convertible note discount

     7,935        7,843        6,750        23,530        20,014   

Impairment of investment, net of foreign exchange effect

     3,711        —          —          3,711        1,724   

Other, net

     6,115        13,673        1,165        30,838        3,671   

Changes in operating assets and liabilities:

     (6,931     69,186        51,406        202,734        105,871   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by operating activities

     102,457        193,226        146,397        544,945        402,313   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

          

Capital expenditures and intangible assets

     (34,766     (38,924     (27,978     (117,655     (70,392

Cash paid for business acquisition

     (400     (8,716     —          (9,116     —     

Net purchases of available-for-sale securities

     (12,075     (23,250     (282,225     (51,963     (371,678

Purchase of equity method investment

     —          —          —          —          (10,740

Receipt of loan payment

     —          —          —          —          8,375   

Proceeds from sale of assets

     —          660        —          660        2,677   

Transfer of restricted cash and investments

     (32     33        3        147        23   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash used for investing activities

     (47,273     (70,197     (310,200     (177,927     (441,735
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

          

Principal payments on long-term debt and capital lease obligations

     (756     (115     (1,024     (1,536     (4,164

Excess tax benefit on equity-based compensation plans

     (903     —          137        (903     2,292   

Net cash received in settlement (paid in advance for) stock repurchase contracts

     —          —          79,189        —          55,194   

Treasury stock purchases

     (243,297     (355,010     (18,909     (953,386     (111,604

Reissuances of treasury stock related to employee stock purchase plan

     8,494        —          7,902        18,419        16,760   

Proceeds from issuance of common stock

     15,132        6,583        301        22,666        1,776   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by (used for) financing activities

     (221,330     (348,542     67,596        (914,740     (39,746
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Effect of exchange rate changes on cash

     (4,934     4,236        (454     2,079        (2,697

Net decrease in cash and cash equivalents

     (171,080     (221,277     (96,661     (545,643     (81,865

Cash and cash equivalents at beginning of period

     1,190,189        1,411,466        1,506,928        1,564,752        1,492,132   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 1,019,109      $ 1,190,189      $ 1,410,267      $ 1,019,109      $ 1,410,267   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

page 6 of 8


Lam Announces Financial Results for the March 2013 Quarter

Non-GAAP Financial Summary

(in thousands, except percentages and per share data)

(unaudited)

 

     Three
Months
Ended
    Three
Months
Ended
 
     March 31,
2013
    December 23,
2012
 

Revenue

   $ 844,928      $ 860,886   

Gross margin

   $ 370,658      $ 380,475   

Gross margin as percentage of revenue

     43.9     44.2

Operating expenses

   $ 296,002      $ 281,499   

Operating income

   $ 74,656      $ 98,976   

Operating margin as a percentage of revenue

     8.8     11.5

Net income

   $ 74,474      $ 77,278   

Net income per diluted share

   $ 0.44      $ 0.45   

Shares used in per share calculation - diluted

     168,504        173,027   

Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income

(in thousands, except per share data)

(unaudited)

 

     Three
Months
Ended
    Three
Months
Ended
 
     March 31,
2013
    December 23,
2012
 

U.S. GAAP net income

   $ 18,996      $ 6,408   

Pre-tax non-GAAP items:

    

Costs associated with rationalization of certain product configurations - cost of goods sold

     207        17,434   

Amortization related to intangible assets acquired in Novellus transaction - cost of goods sold

     20,763        20,745   

Acquisition-related inventory fair value impact - cost of goods sold

     7,448        26,882   

Integration costs - cost of goods sold

     2,408        —     

Integration costs - operating expenses

     13,123        8,971   

Amortization related to intangible assets acquired in Novellus transaction - operating expenses

     19,445        19,438   

Restructuring charges - operating expenses

     —          1,021   

Costs associated with rationalization of certain product configurations - operating expenses

     443        443   

Amortization of convertible note discount, Lam notes - other expense, net

     7,075        6,992   

Amortization of convertible note discount, Novellus assumed notes - other expense, net

     893        821   

Impairment of investment - other expense, net

     3,711        —     

Net tax benefit on non-GAAP items

     (11,700     (14,883

Tax benefit on reinstatement of R&D tax credit

     (11,493     —     

Tax expense associated with legal entity integration

     3,155        —     

Net tax benefit on successful resolution of certain tax matters

     —          (16,994
  

 

 

   

 

 

 

Non-GAAP net income

   $ 74,474      $ 77,278   
  

 

 

   

 

 

 

Non-GAAP net income per diluted share

   $ 0.44      $ 0.45   
  

 

 

   

 

 

 

Number of shares used for diluted per share calculation

     168,504        173,027   

 

page 7 of 8


Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income

(in thousands, except percentages)

(unaudited)

 

     Three
Months
Ended
    Three
Months
Ended
 
     March 31,
2013
    December 23,
2012
 

U.S. GAAP gross margin

   $ 339,832      $ 315,414   

Pre-tax non-GAAP items:

    

Costs associated with rationalization of certain product configurations - cost of goods sold

     207        17,434   

Amortization related to intangible assets acquired in Novellus transaction - cost of goods sold

     20,763        20,745   

Acquisition-related inventory fair value impact - cost of goods sold

     7,448        26,882   

Integration costs - cost of goods sold

     2,408        —     
  

 

 

   

 

 

 

Non-GAAP gross margin

   $ 370,658      $ 380,475   
  

 

 

   

 

 

 

U.S. GAAP gross margin as a percentage of revenue

     40.2     36.6

Non-GAAP gross margin as a percentage of revenue

     43.9     44.2

U.S. GAAP operating expenses

   $ 329,013      $ 311,372   

Pre-tax non-GAAP items:

    

Integration costs - operating expenses

     (13,123     (8,971

Amortization related to intangible assets acquired in Novellus transaction - operating expenses

     (19,445     (19,438

Restructuring charges - operating expenses

     —          (1,021

Costs associated with rationalization of certain product configurations - operating expenses

     (443     (443
  

 

 

   

 

 

 

Non-GAAP operating expenses

   $ 296,002      $ 281,499   
  

 

 

   

 

 

 

Non-GAAP operating income

   $ 74,656      $ 98,976   
  

 

 

   

 

 

 

Non-GAAP operating margin as a percent of revenue

     8.8     11.5

 

page 8 of 8